Is intravenous magnesium sulphate safe to be administered outside the critical care setting?
de Havilland, Amanda, Hariharan, Gopakumar, and Puvvadi, Ramaa (2022) Is intravenous magnesium sulphate safe to be administered outside the critical care setting? Journal of Paediatrics and Child Health, 58 (5). pp. 924-928.
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
Abstract
Aim: To review current evidence regarding the safety of intravenous bolus magnesium sulphate for the treatment of children with acute severe asthma in the non-critical care setting.
Methods: MEDLINE via Ovid, Embase and the Cochrane Library were searched for relevant articles.
Results: Four hundred and eighteen articles were identified during the initial search after removal of duplicates. Eighty full-text articles were selected for review and 16 included as relevant to the clinical question.
Conclusions: Current evidence suggests that bolus intravenous magnesium sulphate is safe to be administered in non-critical care settings provided that line of sight nursing and cardiorespiratory monitoring are available.
Item ID: | 74516 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1440-1754 |
Keywords: | asthma, magnesium, paediatrics; sulphate |
Copyright Information: | © 2022 Paediatrics and Child Health Division (The Royal Australasian College of Physicians). |
Date Deposited: | 01 Nov 2022 02:08 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3213 Paediatrics > 321399 Paediatrics not elsewhere classified @ 100% |
Downloads: |
Total: 1 |
More Statistics |